KEYMED BIOSCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.9 HKD | -0.14% |
|
+27.14% | -28.92% |
| Apr. 12 | Keymed Biosciences Advances Solid Tumors Drug With First Patient Study | MT |
| Mar. 27 | KeyMed Biosciences’ Attributable Loss Widens in 2023 | MT |
Chart calendar Keymed Biosciences Inc.
c2f843bd.p8jGnlLacoYF3qX2OAl45illc_Ch1LFfY6aciPXGUp0.wry3rgaWPPxQ7cazcnBVr0ITBbH5lYhrIMDZz76PZ_HDvo_kYp879TOWnQ~81516f4318c3991b0e2cca969d4c55f5
Upcoming events on Keymed Biosciences Inc.
Past events on Keymed Biosciences Inc.
| 2024-03-26 01:16 pm | Q4 2023 Earnings Release |
| 2023-08-23 | Q2 2023 Earnings Release |
| 2023-03-16 | Q4 2022 Earnings Release |
| 2022-08-28 | Interim 2022 Earnings Release |
| 2022-06-28 02:00 am | Annual General Meeting |
| 2022-03-28 | FY 2021 Earnings Release |
| 2021-08-30 | Interim 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 0,00 | 110 80,0 37.84% | 100 128 -21.83% | 354 356 -0.55% |
|
EBITDA Million CNY | Released Forecast Spread | 0,00 | -402 -287 -40% | -273 -365 25.32% | -287 -259 -10.84% |
|
EBIT Million CNY | Released Forecast Spread | 0,00 | -415 -373 -11.32% | -544 -435 -25.06% | -457 -299 -52.91% |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | -819 | -3 893 -2 126 -83.1% | -304 -320 5.04% | -356 -280 -27.39% |
|
Net income Million CNY | Released Forecast Spread | -819 | -3 887 -2 126 -82.85% | -308 -353 12.74% | -359 -283 -26.86% |
|
EPS CNY | Released Forecast Spread | 0,00 | -24,2 -7,60 -218.03% | -1,18 -1,15 -2.43% | -1,37 -1,04 -31.2% |
| Announcement Date | 25/06/21 | 29/03/22 | 17/03/23 | 26/03/24 |
More events
Past sector events for Keymed Biosciences Inc.
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 2162 Stock
- Calendar Keymed Biosciences Inc.
